Modifiable factors associated with health-related quality of life among lung cancer survivors following curative intent therapy

• Published in: Lung cancer (Amsterdam, Netherlands) Vol. 163; pp. 42 - 50
• Main Authors: Ha, Duc M., Prochazka, Allan V., Bekelman, David B., Stevens-Lapsley, Jennifer E., Studts, Jamie L., Keith, Robert L.
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 01.01.2022
• Subjects: Cancer Survivors; Cross-Sectional Studies; Dyspnea; Humans; Insomnia; Lung; Lung Neoplasms - epidemiology; Lung Neoplasms - therapy; Patient-reported outcome measures; Quality of Life; Recovery of function; Surveys and Questionnaires; Survivorship; BFI; Recovery of function; HRR; LDCT; TLC; EORTC C30/LC13; HFrEF; SOBQ; LLN; QoL; BDS; SD; Dyspnea; DLCO; OSA; US; BMI; CI; CAD; HADS; IQR; Survivorship; 6MWT; SF-36; PTSD; FVC; VIF; Insomnia; Patient-reported outcome measures; FEV1; VASDHS; 6MWD; PSQI; COPD
• ISSN: 0169-5002; 1872-8332
• DOI: 10.1016/j.lungcan.2021.11.012

•Survival after lung cancer is improving but many patients experience disability.•We identified three modifiable factors meaningfully associated with HRQL.•HRQL factors were: exercise-induced dyspnea, impaired role function, and insomnia.•Interventions should target these three factors to improve lung cancer survivorship. The number of lung cancer survivors is increasing along with advances in screening, diagnosis, and treatment. Following curative intent therapy, many lung cancer survivors experience significant health-related quality of life (HRQL) impairments. We sought to identify potentially modifiable factors that contribute to the HRQL of these patients. In this cross-sectional observational study of disease-free, stage I-IIIA lung cancer survivors following curative intent therapy, we used a conceptual model to examine factors that included behavioral, objective functional and physiologic, self-rated function and symptom burden, specific comorbidities, and non-modifiable demographic and clinical lung cancer-related characteristics. We assessed HRQL using the valid and prognostic European Organization for Research and Treatment of Cancer Quality of Life (QoL) Core 30 global health/QoL subscale. We used univariable and multivariable linear regression modeling with backward elimination of potentially modifiable and non-modifiable factors, and interpreted clinically and statistically significant, consistent, and independent modifiable factors as meaningful. Among 75 participants at a median of 12 months since treatment completion, the mean (standard deviation) C30 global health/QoL score was 62.7 (23.3) points (0–100 scale range). In multivariable analysis, with and without non-modifiable factors, we identified three clinically and statistically significant, consistent, and independent factors (unstandardized β range) associated with global health/QoL: 1) abnormal exercise-induced dyspnea (−9.23 to −10.0 points); 2) impaired self-rated role function (or inability to perform work or daily activities and pursuing leisure-time activities) (−12.6 to −16.4 points); and 3) abnormal insomnia (or trouble sleeping) (−12.6 to −16.4 points). We identified meaningful modifiable factors associated with the HRQL of disease-free, stage I-IIIA lung cancer survivors following curative intent therapy. Interventions to improve the HRQL of these patients should aim to reduce exercise-induced dyspnea, improve role function – the ability to perform work and other daily including leisure-time activities, and control insomnia.